Skip to main content
Clinical Trials/ISRCTN54273114
ISRCTN54273114
Completed
N/A

A Prospective Double-Blind, Randomized Clinical Trial of Levocarnitine to Treat Autism Spectrum Disorders

Autism Research Institute (USA)0 sites30 target enrollmentMarch 25, 2010

Overview

Phase
N/A
Intervention
Not specified
Conditions
Autism Spectrum Disorder (ASD)
Sponsor
Autism Research Institute (USA)
Enrollment
30
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 25, 2010
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Autism Research Institute (USA)

Eligibility Criteria

Inclusion Criteria

  • 1\. Subjects diagnosed with an ASD
  • 2\. Aged from 3 to 10 yrs\-old (males and females)
  • 3\. Study subject bodyweights between 13\.2 Kg to 40\.4 Kg

Exclusion Criteria

  • 1\. No study subject previously received carnitine\-based therapy or previous methionine or lysine supplementation
  • 2\. No study subject had any change in therapy or treatment (including medications) within 1 month prior to the study

Outcomes

Primary Outcomes

Not specified

Similar Trials